Ocean Biomedical, Inc. (NASDAQ: OCEA) was formed through the combination of Aesther Healthcare Acquisition Corp. with Ocean Biomedical. Here’s a look at the company’s numbers for the quarter ended September 30, 2022:
![](data:image/svg+xml;charset=utf-8,<svg height="989px" width="1024px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
Infographic: Ocean Biomedical Inc. (OCEA) quarter ended September 30, 2022
Tags: biopharmaceuticals
Related Post
- Earnings Summary: Highlights of Crown Castle’s (CCI) Q4 2024 report
Crown Castle Inc. (NYSE: CCI), a real estate investment trust and a provider of shared…
-
Docusign (DOCU) Earnings: 4Q25 Key Numbers
Docusign, Inc. (NASDAQ: DOCU) reported total revenue of $776.3 million for the fourth quarter of…
-
DG Q4 Call Highlights: Consumer Shifts, Inventory Wins, and Rural Delivery Boom!
Dollar General Corp., a retailer that operates discount stores, in its Q4 earnings call discussed…
